Anti-HLA-A2 antibodies, related chimeric antigen receptors, and uses thereof
US11814432B2 · kind B2 · utility
0Cited by
35References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 20, 2018 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Jan 20, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel anti-HLA-A2 antibody, and to a chimeric antigen receptor comprising said HLA-A2 antibody. The present invention further relates to an immune cell expressing said chimeric receptor antigen, and to therapeutic uses thereof, in particular for treating or preventing graft rejection or GVHD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.